According to the Zhitong Finance App, Goli Pharmaceutical-B (01672) announced that on November 4, 2026, the company granted share options to 42 participants to subscribe for a total of 1.8 million shares of the company's common shares with a face value of 0.0001 US dollars per share. The exercise price of the granted share options was HK$4.923 per share, which is valid for 10 years.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.